Brought to you by 
Kensey Nash gets rights to Orteq's Actifit biomaterial
01 Feb 2011
Executive Summary
Orteq Ltd. (biodegradable polymer technology for meniscus repair) has licensed regenerative medicine firm Kensey Nash Corp. exclusive global manufacturing rights to its Actifit biocompatible synthetic scaffold.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Manufacturing or Supply
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Kensey Nash gets rights to Orteq's Actifit biomaterial
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice